Andere Kunden interessierten sich auch für
![Incidence of Candida albicans In Diabetics with Dental Prosthesis]( "Incidence of Candida albicans In Diabetics with Dental Prosthesis")
Incidence of Candida albicans In Diabetics with Dental Prosthesis19,99 €![Diabetes Mellitus And Lung Functions]( "Diabetes Mellitus And Lung Functions")
Diabetes Mellitus And Lung Functions38,99 €![Physiological Solutions Of Hypertension]( "Physiological Solutions Of Hypertension")
Physiological Solutions Of Hypertension42,99 €![Socioeconomic Impacts of Climate Change in the Sundarbans Area]( "Socioeconomic Impacts of Climate Change in the Sundarbans Area")
Socioeconomic Impacts of Climate Change in the Sundarbans Area32,99 €![Assessment of Wind Energy Potential: The Case of Mehalmeda, Ethiopia]( "Assessment of Wind Energy Potential: The Case of Mehalmeda, Ethiopia")
Assessment of Wind Energy Potential: The Case of Mehalmeda, Ethiopia26,99 €![Clinical Anatomy And Surgical Laparoscopy Of The Abdomen In Goat]( "Clinical Anatomy And Surgical Laparoscopy Of The Abdomen In Goat")
Clinical Anatomy And Surgical Laparoscopy Of The Abdomen In Goat57,99 €![The Forgotten Dimensions Of Water, Sanitation And Hygiene In Africa]( "The Forgotten Dimensions Of Water, Sanitation And Hygiene In Africa")
The Forgotten Dimensions Of Water, Sanitation And Hygiene In Africa26,99 €
Incretins are hormones released from the gut in response to nutrient ingestion that potentiate glucose-stimulated insulin secretion. The search for incretins was prompted by the observation that administration of an oral glucose load leads to a much greater stimulation of insulin response than that obtained when glucose is infused intravenously to give identical blood glucose levels . This difference between the two ways of glucose administration has been attributed to incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose- dependant insulinotropic polypeptide (GIP), involved in the disposal of absorbed glucose, through the stimulation of insulin secretion.Indeed, GLP-1R agonists and DPP-4 inhibitors have been widely and successfully used therapeutic agents in the management of type 2 diabetes.